NCT04933253

Brief Summary

This study will investigate how chest temperature relates to blood loss and blood clotting. Researchers will use infra-red thermometers to measure the temperature of the chest at the end of surgery see if this relates to the amount of blood collected from the surgical drains. In addition, researchers will test if warm irrigation of the chest increases the temperature of the chest and if this impacts blood loss.

Trial Health

30
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Oct 2022

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 14, 2021

Completed
7 days until next milestone

First Posted

Study publicly available on registry

June 21, 2021

Completed
1.3 years until next milestone

Study Start

First participant enrolled

October 1, 2022

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2023

Completed
2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2025

Completed
Last Updated

October 28, 2022

Status Verified

October 1, 2022

Enrollment Period

10 months

First QC Date

June 14, 2021

Last Update Submit

October 25, 2022

Conditions

Outcome Measures

Primary Outcomes (2)

  • Chest temperature

    We will use infra-red thermometers to measure the temperature of the chest at the end of surgery

    At the end of surgery, up to 5 hours

  • Amount of blood loss

    amount of blood drained into the cell-saving device or collection canisters from the chest drains that are left in all patients after surgery

    24 hours after the end of surgery

Study Arms (2)

Experimental

EXPERIMENTAL

this cohort will receive 2 L of warm 37celsius saline irrigation of the mediastinum prior to closure of the chest

Procedure: Saline irrigation

Control

NO INTERVENTION

this cohort will receive the normal standard of care as established by the primary surgeon

Interventions

Mediastinal irrigation with 2 L of 37 degree Celsius saline prior to chest closure

Experimental

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients undergoing open cardiac surgery at VCU
  • Age18 to 80 years
  • American Society of Anesthesiologists Physical Status 1-3

You may not qualify if:

  • history of excessive bleeding
  • partial thromboplastin time \> 35 s
  • prothrombin time \> 35 s
  • fibrinogen \< 200 mg/dL
  • platelet count \< 100,000/L
  • history of infection and fever within 4 weeks before surgery
  • use of steroid or immunosuppressant within 4 weeks before surgery

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Virginia Commonwealth University

Richmond, Virginia, 23298, United States

Location

MeSH Terms

Conditions

Blood Loss, Surgical

Condition Hierarchy (Ancestors)

HemorrhagePathologic ProcessesPathological Conditions, Signs and SymptomsIntraoperative Complications

Study Officials

  • Arturo Cardounel, M.D.

    Virginia Commonwealth University

    PRINCIPAL INVESTIGATOR
0

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 14, 2021

First Posted

June 21, 2021

Study Start

October 1, 2022

Primary Completion

August 1, 2023

Study Completion

August 1, 2025

Last Updated

October 28, 2022

Record last verified: 2022-10

Data Sharing

IPD Sharing
Will not share

Locations